Previous Article | Next Article 
Journal of Virology, August 2001, p. 6769-6775, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.6769-6775.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Frameshift Signal Transplantation and the Unambiguous Analysis of
Mutations in the Yeast Retrotransposon Ty1 Gag-Pol Overlap
Region
Joseph F.
Lawler Jr.,
Gennady V.
Merkulov, and
Jef
D.
Boeke*
Department of Molecular Biology and Genetics,
The Johns Hopkins University School of Medicine, Baltimore,
Maryland 21205
Received 14 December 2000/Accepted 3 May 2001
 |
ABSTRACT |
The yeast retrotransposon Ty1 encodes a 7-nucleotide RNA sequence
that directs a programmed, +1 ribosomal frameshifting event required
for Gag-Pol translation and retrotransposition. We report mutations
that block frameshifting, which can be suppressed in cis
by "transplanting" the frameshift signal to a position upstream of
its native location. These "frameshift transplant" mutants transpose with only a modest decrease in efficiency, suggesting that
the location of the frameshift signal in a functional Ty1 element may
vary. The genomic architecture of Ty1 is such that Gag, Ty1 PR
(PR), and the Gag-derived p4 peptide share a common sequence.
The functional independence of the movement of the frameshift signal to
a new location within the Ty1 element is used to unambiguously attribute the effect of mutations deleterious to transposition in this
region of overlapping coding sequences to effects on the Ty1 (PR). This
work defines the amino terminus of the Ty1 PR and introduces a new
technique for studying viral genome organization.
 |
INTRODUCTION |
Ty1 is one of five endogenous
retrotransposons of the yeast Saccharomyces cerevisiae. The
life cycle of Ty1 begins with transcription of the genomic
element and translation of the resulting mRNA. Like retroviruses,
Ty1 encodes a protease (PR) that processes the element-encoded proteins
(1, 18, 23). Ty1 Gag and Gag-Pol proteins, together with
Ty1 mRNA, form virus-like particles (VLPs), which are
essential transposition intermediates (8, 9). Reverse transcription of Ty1 mRNA takes place in VLPs. The newly synthesized cDNA enters the nucleus and then the yeast genome via an
integration reaction (3, 11, 17).
Viruses and the closely related retrotransposons are under selective
pressure to maintain a small genome. A number of unique strategies have
evolved to ensure that all of the functions necessary for completion of
their life cycle are carried out. Host protein functionalities may be
usurped, obviating the need for a similar, element-encoded protein.
A genome streamlining strategy used by most long terminal
repeat-containing retroelements is programmed ribosomal frameshifting. An mRNA that contains a frameshifting signal can encode multiple proteins, typically Gag and Gag-Pol, in a predetermined stoichiometric ratio that is determined by the efficiency of the frameshift signal. A
frameshift-containing retroelement does not require separate promoters
to drive the transcription of two messages and thereby increases the
information content of its genome with minimal expense. In addition,
the common sequences present in Gag and Gag-Pol direct the assembly of
the Pol proteins into the virion or VLP.
A 7-nucleotide signal in Ty1 mRNA is necessary and sufficient for
directing ribosomal frameshifting (2) and can function translationally in various heterologous contexts. This frameshift signal is required for retrotransposition and is thought to secure the
appropriate Gag and Gag-Pol stoichiometry. The frameshifting signal is
approximately 5 to 10% efficient and therefore results in a 10- to
20-fold excess of the structural protein Gag with respect to Gag-Pol
(6, 7, 21). The Gag-Pol polyprotein contains the enzymatic
components required for Ty1 replication.
Ty1 mRNA can have two translational fates. In the more common
scenario, in which the frameshift signal is read through by the
translating ribosome, a 49-kDa Gag species is made and processed in
trans to a 45-kDa Gag species with concomitant liberation of its carboxy-terminal 40 amino acids. The 49-kDa precursor and 45-kDa
(CA) processed forms migrate with apparent molecular masses of 58 and 54 kDa, respectively. For a complete description of our Ty1
protein nomenclature, see the study by Merkulov et al. (14). The liberated 40-mer, called the p4 peptide, was
suspected to serve some role in particle formation and/or
maturation, because mutations in this region result in
smaller-than-normal VLPs and severe transposition defects
(15). When frameshifting occurs, a Gag-Pol species is
synthesized. Proteolytic processing of Gag-Pol liberates Ty1 PR,
integrase (IN), and reverse transcriptase (RT) from the precursor
polyprotein (10). A 45-kDa Gag species, CA, identical to
that made from Gag is also produced, and we show here that it is
through this processing event that the amino terminus of the PR is
defined (Fig. 1). Most of the p4 peptide
sequence is therefore common to the amino terminus of the PR and the
carboxy terminus of 49-kDa Gag.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic of the p4 region. The Gag and Gag-Pol
polyproteins as well as the relevant amino acids are shown. The amino
acids encoded fully or in part by the frameshift are underlined. The PR
active site residues are in boldface. The PR cleavage sites in Gag and
Gag-Pol are indicated by arrows. The p4 peptide is hatched. The large
black dot represents the site of +1 translational frameshifting. The
stop codon present in Gag is represented by an asterisk. Block
substitution mutations s4 to s12 are
shown as bars underneath the amino acids replaced by the peptide
sequence AAGSAA. The transpositional competence of elements bearing
these mutations is indicated.
|
|
Certain mutations in the p4 region common to Gag, p4, and PR block
transposition. However, interpretation of this mutant phenotype is
complicated by the fact that these mutations simultaneously alter Gag,
PR, and p4 sequences. The transposition defect observed in these
mutants could be secondary to a loss or gain of function in any or all
of these proteins. The functional independence of the frameshift signal
suggests a unique manner by which the critical Ty1 protein(s) affected
by these mutations can be identified.
In this study, we describe the creation of frameshift transplant
mutants of Ty1. These mutants enable us to specifically and unambiguously attribute the deleterious effects of mutations in the p4
region to the Ty1 PR. The p4 peptide, previously thought to be required
for transposition, is shown here to be dispensable. We also physically
define the amino terminus of the PR by microsequencing and thereby
confirm the location of the Gag-PR cleavage site. We confirm that the
mutations in this region affect the N terminus of the Ty1 PR;
frameshift transplant mutants combined in cis with P4 region
mutations are as defective as the same mutants in an otherwise
wild-type Ty1 element. Frameshift transplantation is a novel approach
that permits the isolated study of one or more proteins encoded by a
single mRNA. This approach should prove useful in the study of
viruses that are under selective pressure to maintain small,
information-dense genomes.
 |
MATERIALS AND METHODS |
Strains and plasmids.
All experiments were performed with
S. cerevisiae strain YH51 (MATa
ura3-52 his4-539 lys2-801 spt3-202). All of the yeast
Ty1 expression plasmids were constructed in the context of plasmid
pJEF1105, in which the Ty1 element is marked with the Tn903
neomycin phosphotransferase (neo) gene and carried on a 2µm, URA3-marked plasmid (5).
pD109, containing the fs

mutation (in which the
native Ty1 Gag-Pol frameshift is erased via a 1-bp deletion), was
constructed
by bridge mutagenesis (
12). The sequences of
the oligonucleotides
used in this study are given in Table
1. The template was plasmid
pJEF1081 previously linearized with
MstII. The bridging
oligonucleotide,
JB30, deletes 1 bp from the
GAG-POL overlap
region, merging them
into a single open reading frame (ORF) in plasmid
pJEF1946. Plasmid
pJEF1081 was constructed by substituting the internal
HpaI-
HindIII
fragment from Ty1-912, for the
equivalent fragment in plasmid
pJEF724, an unmarked GAL-Ty1 plasmid
(
4). By this maneuver,
we introduced the frameshift site
of Ty1-912, which, unlike that
of Ty1-H3, contains a unique
MstII site near the frameshift site.
The
BstEII-
BamHI fragment containing the 3' end of
Ty1-
neo was
subcloned into pJEF1946, generating pD109. A
similarly constructed
wild-type Ty1 H3/Ty1-912-
neo element
was transpositionally competent
(not shown). Also, whereas pD109 itself
was not competent for
Ty1 transposition, it was competent for
transposition in the presence
of a plasmid producing only Gag (D. Moore
and J.D.B., unpublished
data).
The fs

mutant, from which the frameshift signal
was removed, was constructed by being subcloned into pJEF1105 as an
HpaI-
BstEII
fragment from pD109. To make the fst1
and fst2 mutants, two PCR
products were synthesized and combined in a
three-piece ligation
with
HpaI-
BstEII-digested
pJEF1105. PCR product 1 was amplified
with primers JB1993 and JB2017
and digested with
HpaI and
BamHI.
PCR product 2 was synthesized with primers JB2016 and JB1994 and
digested with
BamHI and
BstEII. For fst2, PCR product 1 was
synthesized
with JB1992 and JB1993. Product 2 was synthesized with
JB2018
and JB2019. pD109 served as the template in all of these
reactions.
fst1-
s7 and fst1-
s8 were constructed
via PCR-based site-directed
mutagenesis of an
XhoI-
KpnI fragment of the fst1 mutant with
oligonucleotides
JB2626 and JB2628, respectively (
20). The
mutagenized fragments
were subcloned into
pJEF1105.
Prokaryotic expression construct pET3a GagPRHis
6
was prepared via PCR amplification of pD109 with primers JB1378 and
JB1329.
The amplified products were cloned into pET3a via the
NdeI site.
pD109 was used as the template. To construct
pET3a GagPR

His
6,
site-directed mutagenesis was performed on an
XhoI-
SalI
fragment of pD109 in pBluescript with
oligonucleotide JB1553.
This changes the PR active site residues DSG to
EAA and incorporates
a unique
XbaI
site.
pET12a PPRHis
6 was made by PCR amplification of
pD109 with oligonucleotides JB1890 and JB1891. This fragment was cloned
into
the
BamHI site of pET12a. pET12a
PPRHis
6 was prepared via site-directed
mutagenesis with oligonucleotide
JB1553.
PPRHis
6-
s7 and
PPRHis
6-
s8 were synthesized in two
stages via chimeric PCR. For
PPrHis
6-
s7, oligonucleotides JB1890
and JB2537
were used to synthesize product 1 and oligonucleotides
JB2536
and JB1891 were used to synthesize product 2. Similarly for
PPRHis
6-
s8,
oligonucleotide pairs
JB1890 and JB2539 and JB2531 and JB1891
were used to synthesize
products 1 and 2, respectively. The products
of the first reactions
were combined as a template in a second
reaction with primers JB1890
and JB1891. The resulting products
were cloned into the
BamHI site of
pET12a.
Expression and purification of Ty1 PR.
Escherichia
coli strain BL21(DE3), containing various pET vector derivatives,
was inoculated and grown to an optical density at 600 nm
(OD600) of 0.6 in Luria-Bertani medium containing
100 µg of ampicillin per ml and 1 mM
isopropyl-
-D-thiogalactopyranoside. Protein
expression was induced for 4 h at 26°C. Following induction, the
cells were pelleted and lysed via sonication in binding buffer (0.5 M
NaCl, 20 mM Tris-HCl [pH 7.9], 5 mM imidazole, 10% glycerol). The
lysate was cleared by centrifugation in an SS-34 rotor at 19,000 rpm
for 30 min. The His6-tagged protein was purified
under native conditions over Ni-nitrilotriacetic acid resin (Qiagen). The 0.75-ml column was washed with 10 volumes of binding buffer. Ty1PRHis6 fusion protein was eluted in binding
buffer containing 300 mM imidazole.
cDNA synthesis assays.
Yeast cells harboring the indicated
plasmid were grown for 24 h at 24°C in uracil-negative SC
medium containing 2% raffinose (SC
ura, 2% raffinose). The
cells were then diluted to an OD600 of 0.6 and
induced with the addition of galactose to a final concentration of 2%.
Five milliliters of cells at an OD600 of 2.0 was
then pelleted and washed once in water. Nucleic acids were extracted
from the cell pellet by bead beating with glass beads in 400 µl of
DNA extraction buffer (0.5 M NaCl, 20 mM Tris-HCl [pH 7.5], 1 mM
EDTA, 1% sodium dodecyl sulfate), 200 µl of buffer-saturated phenol, and 200 µl of chloroform. The lysate was centrifuged for 10 min in an
Eppendorf microcentrifuge at 14,000 rpm. The supernatant was extracted
with phenol chloroform and then with chloroform before the nucleic
acids were ethanol precipitated. Approximately 10 µg of nucleic acid
was digested with 20 U of EcoRI and 2 µg of RNase A in a
15-µl reaction mixture.
Immunoblotting.
Ty1 expression was induced for 24 h at
24°C as described above. The cell pellets from 2 ml of culture with
an OD600 of 1.0 to 1.5 were lysed in 40 µl of
buffer B-EDTA (20 mM Tris [pH 7.9], 15 mM KCl, 0.1 mM EDTA) with PR
inhibitors and phenylmethylsulfonyl fluoride (1 mM) with a Mini-Bead
Beater (Biospec Products) at a high setting for 1 min. The lysate was
cleared of cell debris by centrifugation in an Eppendorf centrifuge at
14,000 rpm. The protein concentration was determined by the method of
Bradford. Samples (5 µg) were then used for immunoblotting. After
electrophoresis, proteins were transferred to Immobilon membranes at
300 mA for 2 h. Membranes were blocked in 3% milk-0.1% Tween 20 in phosphate-buffered saline (PBS). Primary antibody R2-F was applied
in blocking solution for 1 h at 1:10,000 dilution. The blots were
washed three times for 10 min in PBS-0.1% Tween 20. Secondary
antibody (antirabbit-horseradish peroxidase conjugate [Amersham]) was
applied at a 1:7,500 dilution for 40 min. The membranes were washed as
described above and developed with the Amersham ECL enhanced
chemiluminescent system as per the manufacturer's instructions.
Transposition assays.
Yeast cells, grown as patches, were
replica plated from SC
ura, 2% glucose to SC
ura, 2% galactose
and grown at 26°C for 4 days. The patches were then replica plated to
SC
ura, 2% glucose and grown overnight at 30°C. The patches were
replica plated to yeast-peptone-dextrose (YPD) and, after
overnight growth at 30°C, replica plated to SC plus 0.1%
5-fluoroorotic acid. A portion of the patch was then diluted and plated
on both YPD and YPD plus 75 µg of G418 per ml. The transposition
frequency of the wild-type element is defined as 100%.
 |
RESULTS |
Figure 1 gives a schematic representation of the p4
region of Ty1. This region is defined at its amino terminus by the
Gag-p4 cleavage site and at its carboxy terminus by the Ty1 frameshift signal. The p4 peptide shares sequences with Gag and PR. Block substitution mutations in the region have been described previously: two of them, s7 and s8, block transposition
(15).
The sequence of the carboxy terminus of processed Ty1 CA (capsid)
protein has previously been determined from yeast VLP preparations to
be TARAH (15). This places the CA-p4 cleavage site between amino acids 401 and 402. The p4 peptide liberated by the proteolytic maturation of Gag to CA has not been detected in yeast lysates or VLPs,
however, which raises the possibility that additional proteolytic
events may be responsible for shaping the amino terminus of the PR. If
this is the case, linker insertion mutants in the p4 region that alter
the primary structure of the protein might block such further
processing and thereby compromise transposition.
Definition of the Ty1 PR N terminus.
To determine the identity
of the amino terminus of Ty1 PR, as defined by autoproteolytic
processing, we expressed it in E. coli. Two series of
constructs were prepared (Fig. 2A). The
first contained the entire Gag ORF in frame with the PR ORF, and the endogenous frameshift signal was "erased," via the
fs
mutation, to permit expression in E. coli, in which the frameshift signal is nonfunctional. A
carboxy-terminal hexahistidine tag was affixed to facilitate
purification. Control constructs in which an active site mutation (DSG
to EAA) was introduced in the PR were also prepared.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Expression of Gag-PR in E. coli and
demonstration of autoprocessing. (A) Schematic representation of the
expression constructs used to generate the underlying blots. The
carboxy-terminal hexahistidine tag is shown in black. Relevant
amino acid positions are shown. (B) Immunoblot of bacterial
lysates in which the Gag-PR constructs were expressed. VLPs from yeast
were separated in lane 1. (C) Appearance of the PR following expression
of the PPR precursor protein. Polyclonal antibody R2-F, used in the
immunoblot shown in panel B, recognizes Ty1 Gag. Antipeptide
antibody JH695 (15), directed against an epitope in the p4
region, was used in the immunoblot shown in panel C.
|
|
The GagPRHis
6 fusion is expressed as an 85-kDa
precursor polypeptide in
E. coli and is incompletely
processed into two products.
The intact fusion as well processed
product can be detected with
anti-Gag antibody; their electrophoretic
mobilities correspond
to those of the full-length and processed
products, respectively
(Fig.
2B). The latter product comigrates with
authentic Ty1 CA
from VLPs. Antibodies raised against a synthetic
peptide corresponding
to amino acids 418 to 440 of Ty1 Gag detect
an immunoreactive
band at approximately 29 kDa that
corresponds to the Ty1 PR (Fig.
2C). The
GagPRHis
6 precursor and the Ty1 PR bands could
also be
detected by antihexahistidine antibodies (data not shown). No
processing is observed in lysates prepared from
GagPRHis
6-expressing
bacteria, as evidenced by a
single 85-kDa band on the immunoblot
detected with anti-Gag antibody
(Fig.
2B). Taken together, these
findings strongly suggest that the
processing observed is autocatalytic
and not the result of an
adventitious
E. coli PR.
A second series of constructs were prepared in which the first 300 amino acids of Gag were replaced with a 45-residue periplasmic
targeting signal. These constructs, denoted PPR, are efficiently
expressed and are capable of more complete autocatalytic processing.
The processed PPRHis
6 fusion proteins were
purified from cells
expressing the GagPRHis
6
construct and the PPRHis
6 construct and
subjected
to N-terminal microsequencing. The first five residues
of
PRHis
6 from the GagPRHis
6
construct were determined to be NVSTS.
The first seven residues of
PRHis
6 from the PPRHis
6
construct
were determined to be NVSTSNN (Table
2). These sequences precisely
match the
predicted amino terminus of the PR, assuming it is produced
by cleavage
similar to that producing CA and p4. The identity
of the
carboxy-terminal residue of the CA protein was independently
determined
to be NNSKSKTARAH via mass spectroscopic analysis of
Ty1 VLPs (J.F.L.,
R. Newitt, R. Aebersold, and J.D.B., unpublished
results). We conclude
that the carboxy terminus of Gag and the
amino terminus of the PR are
defined by a single autocatalytic
processing event. For reasons
that are unclear, we have been unable
to detect the Ty1 PR by
immunoblotting to confirm that it comigrates
with the heterologously
produced PR. However, in the mass spectroscopic
analysis, we also found
the PR-derived peptide IRSAHHIHSASSNPDINVVDAQKR
in VLP
preparations, directly confirming the presence of PR in
VLPs
(
10).
The possibility that mutations in the p4 region alter the specificity
of autoprocessing and thereby compromise transposition
was addressed by
expressing PPR constructs bearing the
s7 or
s8
mutation and microsequencing their cleavage site.
However, the
autoprocessing sites in
s7 and
s8 mutants are identical to those
in the wild type (Table
2). These results suggest that the transposition
defects observed
in
s7 and
s8 Ty1 elements do not result from
aberrant processing at the Gag-PR
junction.
Frameshift signal transplantation.
The endogenous +1
frameshift signal is essential for Ty1 transposition and is
believed to secure the appropriate stoichiometry of Gag and the Gag-Pol
polyprotein. It is located in a region of the Ty1 genome that encodes
the carboxy terminus of Gag and the amino terminus of the PR (Fig. 1).
The minimal frameshift signal is only 7 nucleotides long and can
function independently of the surrounding context.
We reasoned that erasing the endogenous frameshift signal and
relocating it to a region permissive for amino acid substitution
mutants immediately adjacent to the Gag-PR cleavage site would
result
in an element incapable of producing the p4 peptide as
a part of the
Ty1 Gag protein (
15). In these constructs, Gag
should be
synthesized exclusively as a CA protein with four extra
C-terminal
amino acids. To avoid complementation of the mutant
elements in
trans, a host strain (YH51) in which endogenous Ty1
elements
are not expressed was used. This strain lacks the
SPT3 gene,
which is required for genomic Ty1 element transcription
(
22).
To erase the endogenous signal, its sequence, CTTAGGC, was replaced
with CTGGGC, which deletes one nucleotide, substitutes
a second (T

G), and preserves the native amino acid sequence
of Gag-Pol. Ty1
elements in which the frameshift signal has been
erased show a 100-fold
decrease in transposition frequency (Fig.
3). The CA and IN proteins are detected
in cell lysates, however,
suggesting that proteolytic processing is not
impaired (Fig.
4).
These frameshift-null
mutants do form VLPs, but do not synthesize
cDNA (Fig.
5). No Gag immunoreactivity is observed
in the control
lysates (Fig.
4, lane 1), independently confirming that
the host
strain does not express endogenous Ty1 elements.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 3.
A schematic representation of the frameshift transplant
constructs. The wavy line represents Ty1 mRNA. The transposition
efficiency in strain YH51 is shown. The sequences surrounding the PR
cleavage sites are shown in the wild-type (WT or wt) construct.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Frameshift transplant mutants produce the expected Gag
proteins. A Western blot probed with polyclonal antibody R2-F, which
recognizes Gag, is shown. Five micrograms of total yeast lysate from
strain YH51 was loaded in each lane. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (9% polyacrylamide) was
used to separate the Gag species. Lysates from a PR active site mutant
(derived from pGM17) (16) are shown for comparison. pRS
refers to plasmid pRS326, a 2µm, URA3-marked plasmid.
The Gag immunoreactive band in the fst1 lane migrates as a tight
doublet. The doublet cannot be resolved to a singlet with phosphatase
treatment. The mobilities of the upper band in the fst1 doublet and of
the 56-kDa fst2 species are consistent with the predicted mobilities of
the unprocessed Gag species for these mutants. WT, wild type.
|
|

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 5.
The frameshift transplant mutants reverse transcribe
Ty1-neo mRNA. Total yeast nucleic acids from strain
YH51 were digested with EcoRI, treated with RNase A, and
separated on a 1% agarose gel. This gel was probed with
32P-labeled DNA generated from an
XhoI-HindIII fragment of the
Tn903 neo gene via random hexamer
labeling. The lane background results from Ty1-neo
insertions into yeast genomic DNA. WT, wild type.
|
|
Amino acid residues 405 to 422 of Gag (4 to 21 of PR) can be
substituted for without adversely affecting transposition
(
15).
Therefore, a new frameshift signal was inserted in
this area (Fig.
3). Nucleotides 1512 through 1525 were substituted for
with a
15-nucleotide cassette that contains a frameshift signal
immediately
followed by an ochre termination codon. This manipulation
does
not alter the length of the Ty1 transcript. The net effect is
relocation of the frameshift signal immediately downstream of
the
Gag-PR cleavage
site.
This frameshift transplant mutant (fst1) transposes at modestly reduced
frequency (47% of that of the wild type) (Fig.
3),
demonstrating that
erasure of the endogenous frameshift can be
suppressed in
cis by introducing a wild-type copy of the frameshift
signal
upstream of it. As predicted, only a CA-sized species is
observed (Fig.
4). The frameshift signal is therefore not limited
to its native
position in Ty1 mRNA. Interestingly, the extent
of the
transposition defect is closely paralleled by a decreased
level of cDNA
synthesis (Fig.
5).
A second frameshift transplant mutant was prepared in which
the frameshift signal was relocated to a region approximately
halfway into the p4 region. This construct (fst2) also transposes
with
only a modest reduction in efficacy (Fig.
3). In lysates
from cells
expressing this construct, Ty1 CA and a Gag species
approximately 2 kDa
larger than native CA can be detected if the
relocated frameshift is
functional, and the larger form of Gag
presumably serves as a substrate
for Ty1 PR (Fig.
4). The levels
of cDNA synthesized by this mutant are
also slightly reduced and
consistent with the observed transposition
defect (Fig.
5). Both
fst1 and fst2 produced VLPs that behave
indistinguishably from
wild-type VLPs on sucrose density
gradients.
We also tested the ability of these frameshift transplant mutants to
transpose in a
rad52 spt3 yeast strain (BY3227).
RAD52 is required for multiple cellular functions, including
homologous
recombination and the repair of double-stranded breaks in
cellular
DNA. Newly synthesized Ty1 cDNA can enter the host genome via
Ty1 integrase-mediated targeted integration or via homologous
recombination with an existing element (
13,
19). The
latter
pathway is
RAD52 dependent. If the p4 region that is
deleted as
part of Gag in the frameshift transplant constructs is
required
for targeted recombination, then a transposition defect may
not
be unmasked in a
RAD52 background. While the overall
efficiency
of transposition was decreased in a
rad52 spt3
mutant strain,
the relative efficiencies were preserved (data not
shown). We
therefore conclude that the p4 region is not required for
targeted
integration.
While the p4 region is dispensable for transposition, it remains
formally possible that linker insertion mutations in the
p4 region
confer a gain-of-function phenotype upon Ty1 Gag. This
gain of function
could be responsible for the observed transposition
defect. To address
this possibility, we constructed linker insertion
mutations
s7 and
s8, which are known to block
transposition, in
the context of frameshift transplant mutant no. 1 (fst1). The
fst1-
s7 and fst1-
s8 double mutants
were then tested for transpositional
competence. As shown in
Fig.
6, neither of the double mutants
is
capable of transposition. Linker insertion
s7 and
s8 mutants
do not compromise Ty1 PR activity
(
15). This result effectively
rules out the possibility
that a gain of function in Ty1 Gag or
p4 is responsible for the
transposition defect observed in the
s7 or
s8
mutants.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
Schematic of frameshift transplant s7 and
s8 double mutants. Transposition frequencies in strain
YH51 are indicated. The transposition frequencies reported are typical
and did not vary by more than 5% in any independent experiment. WT or
wt, wild type.
|
|
 |
DISCUSSION |
This study describes a novel technique called frameshift
transplantation. This technique allows a previously unattainable insight into the relationship between the carboxy terminus of Ty1 CA
and the amino terminus of the Ty1 PR and the p4 peptide. The
amino-terminal sequence of the Ty1 PR is generated by the same cleavage
that generates the carboxy terminus of Ty1 CA. Ty1 CA protein can be
made in one of two ways: as the product of Gag-p49 processing or via
processing of Gag-Pol-p199. We have shown that the cleavage site in
both of these cases is the same. The p4 peptide liberated by the
proteolysis of Gag-p49 to CA (Gag-p45) is shown to be dispensable for
transposition. Mutations in the p4 region that block transposition are
conclusively demonstrated to be uniquely attributable to an effect on
the PR through the use of the frameshift transplant technique.
The exact positions of the Ty1 PR cleavage sites between PR and
integrase (PR/IN) and integrase and reverse transcriptase (IN/RT) have
previously been reported. The positions of these cleavage sites were
recently confirmed by analysis of PR cleavage site mutants
(14). The Gag-PR cleavage site was mapped based on the
carboxy-terminal sequencing of endogenous Gag protein and confirmed by
mass spectroscopic analysis (15). However, because we have
never detected the p4 peptide in cell lysates or VLPs, it remained
possible that additional events (such as multiple proteolytic
cleavages) shaped the amino terminus of the PR. Heterologous expression
of two different constructs confirms that the N terminus of the PR
corresponds to its predicted position based on the C terminus of CA.
In this paper, the p4 region was shown to be dispensable for
transposition both as part of the carboxy terminus of Gag and as an
independent peptide. This was done by relocating the frameshift signal
such that the p4 peptide sequence is expressed exclusively as part of
the PR. The p4 peptide is similar in size to other retroviral
nucleocapsid proteins, and it was thought that it might serve in a
similar capacity. Recent evidence from our laboratory has shown the
N-terminal segment of PR may facilitate at least one nucleocapsid-like
function (J.F.L., G.M., and J.D.B., submitted for publication).
Ty1 cDNA can enter the host genome via targeted integration, an
integrase-dependent event, or by homologous integration, a RAD52-dependent event (19). If the p4 region
was necessary for targeted integration, it might have been possible for
Ty1 cDNA synthesized by these mutants to enter the host genome via
homologous recombination. However, we found that the frameshift
transplant constructs were capable of transposition even in a
rad52 spt3 strain background. This effectively rules out any
role for the p4 region of Ty1 Gag and the p4 peptide in targeted integration.
Frameshift signals are found in a majority of retroviruses. In fact,
the human T-cell leukemia virus type 1 and the mouse mammary tumor
virus contain two independent frameshift signals. Many retroviruses
position their frameshift signal between the structural and enzymatic
components of the virus. The positioning typically ensures that
structural components are synthesized in excess of the enzymatic
components. The fact that we are able to relocate the frameshift signal
and retain a functional retroelement raises interesting questions
regarding how frameshifts arose in retroelement evolution. Both
functional frameshift transplant constructs transpose at slightly
reduced efficiencies, suggesting that the position of the native
frameshift sequence may have evolved to maximize transposition frequency.
Among yeast retrotransposons, Ty1, the closely related Ty2 element, and
the more distantly related Ty3 and Ty4 contain +1 frameshifting
signals. Interestingly, only Ty1, Ty2, and Ty4 use the conserved
7-nucleotide motif CTT AGG C. The stop codon in Ty2 is predicted to
produce a similar 4-kDa peptide by proteolysis. However, in Ty4, the
Gag stop codon is located downstream of the PR active site residues.
The peptide released from the Ty4 Gag C terminus is therefore
considerably longer than its analogs in Ty1 and Ty2.
It has been shown that mutations in the C-terminal Gag-p6 peptide in
human immunodeficiency virus might affect particle release from the
cell, although little effort was made to distinguish between the
effects of these mutations on the p6 and overlapping sequences
(24). The generality of the frameshift transplant approach
suggests that it can be used to genetically separate the effects of
mutations that affect sequences present in multiple viral proteins.
 |
ACKNOWLEDGMENTS |
J. F. Lawler, Jr., and G. V. Merkulov contributed
equally to this work.
We thank Daniel Moore for technical assistance and David Garfinkel
for communicating unpublished data.
This work was supported by NIH grant GM 36481 to J.D.B. and Medical
Scientist Training grant GM-07309 to J.F.L.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205. Phone: (410) 955-0398. Fax: (410) 614-2987. E-mail: jboeke{at}jhmi.edu.
 |
REFERENCES |
| 1.
|
Adams, S. E.,
J. Mellor,
K. Gull,
R. B. Sim,
M. F. Tuite,
S. M. Kingsman, and A. J. Kingsman.
1987.
The functions and relationships of Ty-VLP proteins in yeast reflect those of mammalian retroviral proteins.
Cell
49:111-119[CrossRef][Medline].
|
| 2.
|
Belcourt, M. F., and P. J. Farabaugh.
1990.
Ribosomal frameshifting in the yeast retrotransposon Ty: tRNAs induce slippage on a 7 nucleotide minimal site.
Cell
62:339-352[CrossRef][Medline].
|
| 3.
|
Boeke, J. D., and S. E. Devine.
1998.
Yeast retrotransposons: finding a nice quiet neighborhood.
Cell
93:1087-1089[CrossRef][Medline].
|
| 4.
|
Boeke, J. D.,
D. J. Garfinkel,
C. A. Styles, and G. R. Fink.
1985.
Ty elements transpose through an RNA intermediate.
Cell
40:491-500[CrossRef][Medline].
|
| 5.
|
Boeke, J. D.,
H. Xu, and G. R. Fink.
1988.
A general method for the chromosomal amplification of genes in yeast.
Science
239:280-282[Abstract/Free Full Text].
|
| 6.
|
Clare, J. J.,
M. Belcourt, and P. J. Farabaugh.
1988.
Efficient translational frameshifting occurs within a conserved sequence of the overlap between the two genes of a yeast Ty1 transposon.
Proc. Natl. Acad. Sci. USA
85:6816-6820[Abstract/Free Full Text].
|
| 7.
|
Dinman, J. D., and R. B. Wickner.
1992.
Ribosomal frameshifting efficiency and gag/gag-pol ratio are critical for yeast M1 double-stranded RNA virus propagation.
J. Virol.
66:3669-3676[Abstract/Free Full Text].
|
| 8.
|
Eichinger, D. J., and J. D. Boeke.
1988.
The DNA intermediate in yeast Ty1 element transposition copurifies with virus-like particles: cell-free Ty1 transposition.
Cell
54:955-966[CrossRef][Medline].
|
| 9.
|
Garfinkel, D. J.,
J. D. Boeke, and G. R. Fink.
1985.
Ty element transposition: reverse transcriptase and virus-like particles.
Cell
42:507-517[CrossRef][Medline].
|
| 10.
|
Garfinkel, D. J.,
A.-M. Hedge,
S. D. Youngren, and T. D. Copeland.
1991.
Proteolytic processing of pol-TYB proteins from the yeast retrotransposon Ty1.
J. Virol.
65:4573-4581[Abstract/Free Full Text].
|
| 11.
|
Kenna, M. A.,
C. B. Brachmann,
S. E. Devine, and J. D. Boeke.
1998.
Invading the yeast nucleus: a nuclear localization signal at the C terminus of Ty1 integrase is required for transposition in vivo.
Mol. Cell. Biol.
18:1115-1124[Abstract/Free Full Text].
|
| 12.
|
Mandecki, W., and M. H. Caruthers.
1984.
Mutants of the lac promoter with large insertions and deletions between the CAP binding site and the 35 region.
Gene
31:263-267[CrossRef][Medline].
|
| 13.
|
Melamed, C.,
Y. Nevo, and M. Kupiec.
1992.
Involvement of cDNA in homologous recombination between Ty elements in Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:1613-1620[Abstract/Free Full Text].
|
| 14.
|
Merkulov, G. V.,
J. F. Lawler, Jr.,
Y. Eby, and J. D. Boeke.
2001.
Ty1 proteolytic cleavage sites are required for transposition: all sites are not created equal.
J. Virol.
75:638-644[Abstract/Free Full Text].
|
| 15.
|
Merkulov, G. V.,
K. M. Swiderek,
C. B. Brachmann, and J. D. Boeke.
1996.
A critical proteolytic cleavage site near the C terminus of the yeast retrotransposon Ty1 Gag protein.
J. Virol.
70:5548-5556[Abstract/Free Full Text].
|
| 16.
|
Monokian, G. M.,
L. T. Braiterman, and J. D. Boeke.
1994.
In-frame linker insertion mutagenesis of yeast transposon Ty1: mutations, transposition and dominance.
Gene
139:9-18[CrossRef][Medline].
|
| 17.
|
Moore, S. P.,
L. A. Rinckel, and D. J. Garfinkel.
1998.
A Ty1 integrase nuclear localization signal required for retrotransposition.
Mol. Cell. Biol.
18:1105-1114[Abstract/Free Full Text].
|
| 18.
|
Muller, F.,
K. H. Bruhl,
K. Freidel,
K. V. Kowallik, and M. Ciriacy.
1987.
Processing of TY1 proteins and formation of Ty1 virus-like particles in Saccharomyces cerevisiae.
Mol. Gen. Genet.
207:421-429[CrossRef][Medline].
|
| 19.
|
Sharon, G.,
T. J. Burkett, and D. J. Garfinkel.
1994.
Efficient homologous recombination of Ty1 element cDNA when integration is blocked.
Mol. Cell. Biol.
14:6540-6551[Abstract/Free Full Text].
|
| 20.
|
Turchin, A., and J. F. Lawler, Jr.
1999.
The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis.
BioTechniques
26:672-676[Medline].
|
| 21.
|
Wilson, W.,
M. H. Malim,
J. Mellor,
A. J. Kingsman, and S. M. Kingsman.
1986.
Expression strategies of the yeast retrotransposon Ty: a short sequence directs ribosomal frameshifting.
Nucleic Acids Res.
14:7001-7016[Abstract/Free Full Text].
|
| 22.
|
Winston, F.,
K. J. Durbin, and G. R. Fink.
1984.
The SPT3 gene is required for normal transcription of Ty elements in S. cerevisiae.
Cell
39:675-682[CrossRef][Medline].
|
| 23.
|
Youngren, S. D.,
J. D. Boeke,
N. J. Sanders, and D. J. Garfinkel.
1988.
Functional organization of the retrotransposon Ty from Saccharomyces cerevisiae: Ty protease is required for transposition.
Mol. Cell. Biol.
8:1421-1431[Abstract/Free Full Text].
|
| 24.
|
Yu, S. F.,
K. Edelmann,
R. K. Strong,
A. Moebes,
A. Rethwilm, and M. L. Linial.
1996.
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains.
J. Virol.
70:8255-8262[Abstract].
|
Journal of Virology, August 2001, p. 6769-6775, Vol. 75, No. 15
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.15.6769-6775.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Curcio, M. J., Kenny, A. E., Moore, S., Garfinkel, D. J., Weintraub, M., Gamache, E. R., Scholes, D. T.
(2007). S-Phase Checkpoint Pathways Stimulate the Mobility of the Retrovirus-Like Transposon Ty1. Mol. Cell. Biol.
27: 8874-8885
[Abstract]
[Full Text]
-
BOLTON, E. C., COOMBES, C., EBY, Y., CARDELL, M., BOEKE, J. D.
(2005). Identification and characterization of critical cis-acting sequences within the yeast Ty1 retrotransposon. RNA
11: 308-322
[Abstract]
[Full Text]
-
Lawler, J. F. Jr., Haeusser, D. P., Dull, A., Boeke, J. D., Keeney, J. B.
(2002). Ty1 Defect in Proteolysis at High Temperature. J. Virol.
76: 4233-4240
[Abstract]
[Full Text]
-
Lawler, J. F. Jr., Merkulov, G. V., Boeke, J. D.
(2002). A Nucleocapsid Functionality Contained within the Amino Terminus of the Ty1 Protease That Is Distinct and Separable from Proteolytic Activity. J. Virol.
76: 346-354
[Abstract]
[Full Text]